We're Keeping An Eye On Cogent Biosciences' (NASDAQ:COGT) Cash Burn Rate [Yahoo! Finance]
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
Cogent Biosciences, Inc. (NASDAQ: COGT) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference [Yahoo! Finance]
Cogent Biosciences, Inc. (NASDAQ: COGT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $17.00 price target on the stock.